Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT03339856
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with treatment-naïve idiopathic central serous chorioretinopathy
Exclusion Criteria:
* age \> 55 years,
* Clinical or angiographic features suggestive of choroidal neovascularization
* Optical coherence tomography findings suggestive of type 1 neovascularization or polypoidal choroidal vasculopathy (e.g., double layer sign or fibrovascular pigment epithelial detachment).
* History of macular laser photocoagulation, photodynamic therapy, or anti-vascular-endothelial growth factor therapy.
* History of exogenous corticosteroid treatment for a systemic disease (e.g., Cushing's syndrome or renal disease).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
55 Years
Study:
NCT03339856
Study Brief:
Protocol Section:
NCT03339856